Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Pre-oxygenation in Cardiac Surgery with Pulmonary Hypertension
NCT02345616Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2015
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nitric oxide in pulmonary hypertension (PH), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Pulmonary arterial systolic, diastolic and mean pressure at Day 1, Pulmonary arterial mean/arterial mean ratio at Day 1 and 8 more. Status: unknown.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02345616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345616.